期刊文献+

45例宫颈原位腺癌临床分析

Clinical analysis of 45 cases of cervical adenocarcinoma in situ
原文传递
导出
摘要 目的探讨宫颈原位腺癌(adenocarcinoma in situ,AIS)的临床特征、诊断及治疗方式的选择。方法回顾性分析2014年1月至2020年12月在本院确诊的45例AIS患者的临床资料,分析其临床特征、宫颈癌筛查结果、治疗方式及预后,比较不同诊断及治疗方式的准确性及优势。结果45例患者中,宫颈AIS的发病年龄为(41.5±8.8)岁;阴道流血(31.1%,14/45)是发病最主要的临床症状;人乳头瘤病毒(HPV)16型(31.3%,14/45)和18型(51.1%,23/45)是最常见的感染类型;宫颈锥切术(90.0%,36/40)在明确AIS中效果最显著;阴道镜下活检首次发现AIS占60.0%(18/30);宫颈细胞学(6.7%,2/30)相较于HPV检测(97.6%,40/41)、阴道镜下活检(60.0%,18/30)相较于宫颈锥切术(90.0%,36/40)在发现AIS中差异有统计学意义(P<0.01)。宫颈细胞学、阴道镜下活检、宫颈锥切术在首次发现AIS上差异有统计学意义(P<0.001)。结论阴道流血是宫颈AIS最主要的临床特征;HPV16/18型感染是其主要原因;宫颈细胞学联合HPV检测可提高AIS的诊断率;阴道镜下活检在检出AIS中具有重要作用。 Objective To investigate the pathogenesis,clinical features,diagnosis and treatment of cervical adenocarcinoma in situ(AIS).Methods The clinical data of 45 patients diagnosed with AIS from Jan,2014 to Dec,2020 were retrospectively analyzed.The clinical characteristics,cervical cancer screening results,treatment methods and prognosis were analyzed and the accuracy and advantages of different diagnosis and treatment methods were compared.Results Among the 45 patients,the age of AIS was(41.5±8.8)years.Vaginal bleeding(31.3%,14/45)was the most common clinical symptom.Human papilloma virus(HPV)types 16(31.3%,14/45)and 18(51.1%,23/45)were the most common types of infection in AIS lesions.Cervical conization(90.0%,36/40)was most effective method in identifying AIS lesions.Colposcopic biopsy(60.0%,18/30)was higher in the first detection of AIS.Comparing with cytology(6.7%,2/30)and colposcopy(60.0%,18/30),HPV test(97.6%,40/41)and cervical conization(90.0%,36/40)had higher AIS detection rate,the difference was statistically significant(P<0.05).Cytology,colposcopy and cervical conization showed statistically significant differences in the first detection of AIS(P<0.001).Conclusions Vaginal bleeding is the primary clinical feature of AIS.HPV 16/18 infection is the main cause.The combined cytology and HPV test can improve the diagnosis rate of AIS.Colposcopic biopsy plays an important role in the detection of AIS lesions.
作者 吴雨桐 贾英 WU Yutong;JIA Ying(Department of Gynecology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400000,China)
出处 《中国妇产科临床杂志》 CSCD 2023年第2期137-139,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 宫颈原位腺癌 宫颈脱落细胞学 人乳头瘤病毒 阴道镜 子宫颈锥切术 cervical adenocarcinoma in situ cytology human papillomavirus colposcopy conization
  • 相关文献

参考文献6

二级参考文献44

  • 1韦梦娜,余艳琴,徐慧芳,富诗岚,胡尚英,赵方辉,乔友林.中国大陆地区不同宫颈病变人群中人乳头瘤病毒感染率及型别分布的系统研究[J].中国肿瘤临床与康复,2020,0(2):133-137. 被引量:23
  • 2回允中主译.妇产科诊断病理学.北京:北京大学医学出版社,2007:357-358.
  • 3Hepler TK, Dockerty MB, Randall LM. Primary adenocarci noma of the cervix. Am J ObstetGynecol, 1952, 63: 800-808.
  • 4Friedell GH, Mc KD. Adenocarcinoma in situ of the endocer- vix. Cancer, 1953, 6: 887-897.
  • 5Jaworski RC. Endocervieal glandular dysplasia, adenocarci- noma in situ, and early invasive (microinvasive) adenocarci- noma of the uterine cervix. SeminDiagnPathol, 1990, 7: 190 - 204.
  • 6Colgan TJ, Lickrish GM. The topography and invasive po- tential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia. Gynecol Oncol, 1990, 36: 246 - 249.
  • 7Ostor AG, Duncan A, Quinn M, et al. Adenocarcinoma in situ of the uterine cervix., an experience with 100 cases. Gynecol Oncol, 2000, 79: 207-210.
  • 8Krane JF, Granter SR, Trask CE, et al. Papanicolaou smear sensitivity for the detection of ad of the cervix a study of 49 cases. Cancer, 2001, 93: 8- 15.
  • 9Lee KR, Minter LJ, Granter SR. Papanieolaou smear sensi- tivity for ad in situ of the cervix. A study of 34 cases. Am] ClinPathol, 1997, 107: 30-35.
  • 10Polterauer S, Reinthaller A, Horvat R, et al. Cervical adeno- carcinoma in situ: update and management. Current Obstet- rics and Gynecology Reports, 2013, 2: 86- 93.

共引文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部